Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 10, 2020
Previous Article Next Article

Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent

Author affiliations

Abstract

A contrast agent (CA) in magnetic resonance imaging (MRI) is now an essential add-on to obtain high-quality contrast-enhanced anatomical images for disease diagnosis and monitoring the treatment response. However, the rapid elimination of CAs by the immune system and excretion by the renal route has limited its application. As a result, the CA dose for effective contrast is ever-increasing, resulting in toxic side effects such as gadolinium (Gd) related nephrogenic systemic fibrosis (NSF) toxicity. Considering the widespread application of Gd-based CAs, it is now very important to revisit their formulation in order to improve their local concentration and minimize their dose while achieving clinical goals. Therefore, we have adapted a unique strategy to maximize Gd delivery to the target site using macrophage cell-derived extracellular vesicles (EVs) reconstructed with a Gd-conjugated liposomal system herein called gadolinium infused hybrid EVs (Gd-HEVs). We hypothesize that Gd-HEVs, owing to the presence of immune cell-derived EV protein cargo, can effectively disguise themselves as a biological entity, prolong the retention time for contrast enhancement, and show tumor specificity. Incorporation of Gd into nanoformulations can enhance the longitudinal relaxivity r1 by reducing the tumbling rate of paramagnetic metal complexes. Here, Gd-HEVs showed a higher r1 relaxivity of 9.86 mM−1 s−1 compared to 3.98 mM−1 s−1 of Magnevist® at an equivalent Gd concentration, when measured by clinical 3T MRI. This will allow us to reduce the clinically used Gd concentration about three-fold while maintaining contrast in the clinical window thereby supporting our hypothesis. Furthermore, Gd-HEVs showed a preferential cellular interaction and accumulation towards cancer cells compared to non-cancer cells, both in vitro and in vivo. More importantly, Gd-HEVs showed excellent contrast enhancement in the blood vasculature with a higher retention time compared to its counterpart, Magnevist®. Our study successfully showed that the incorporation of Gd in the EV framework can help to enhance the contrast ability, and therefore it can be a platform technology for the development of safer MRI contrast agents.

Graphical abstract: Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent

Back to tab navigation

Supplementary files

Article information


Submitted
21 Jan 2020
Accepted
05 Apr 2020
First published
07 Apr 2020

Biomater. Sci., 2020,8, 2887-2904
Article type
Paper

Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent

S. Rayamajhi, R. Marasini, T. D. T. Nguyen, B. L. Plattner, D. Biller and S. Aryal, Biomater. Sci., 2020, 8, 2887
DOI: 10.1039/D0BM00128G

Social activity

Search articles by author

Spotlight

Advertisements